| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/MPA.0000000000000487 |
| P698 | PubMed publication ID | 26355546 |
| P50 | author | Henrik Krarup | Q42767014 |
| P2093 | author name string | Poul Henning Madsen | |
| Ole Thorlacius-Ussing | |||
| Stine Dam Henriksen | |||
| P433 | issue | 7 | |
| P921 | main subject | hypermethylation | Q106875739 |
| pancreatic cancer | Q212961 | ||
| P304 | page(s) | 1036-1045 | |
| P577 | publication date | 2015-10-01 | |
| P1433 | published in | Pancreas | Q15762014 |
| P1476 | title | DNA Hypermethylation as a Blood-Based Marker for Pancreatic Cancer: A Literature Review | |
| P478 | volume | 44 |
| Q52603515 | A Contemporary Review of the Treatment Landscape and the Role of Predictive and Prognostic Biomarkers in Pancreatic Adenocarcinoma. |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q41766645 | Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma |
| Q47162128 | Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma |
| Q64115892 | Cell-free DNA testing: future applications in gastroenterology and hepatology |
| Q49166927 | Comprehensive analysis of gene expression and DNA methylation datasets identify valuable biomarkers for rheumatoid arthritis progression |
| Q41840249 | HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study |
| Q103038645 | Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer |
| Q48149907 | Promoter hypermethylation in plasma-derived cell-free DNA as a prognostic marker for pancreatic adenocarcinoma staging |
| Q89855559 | Tumor-Insular Complex in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma Is Associated With Higher Residual Tumor |
Search more.